SCHEMBL10101752

SCHEMBL10101752

COc1ccc(-c2cc(C)c(O)cc2/C(C)=N/OCc2ccc(C)cc2)cc1OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.41
HPGD P15428 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HSP90AA1 P07900 1/20 0.40
S1PR1 P21453 2/20 0.37
MAPT P10636 7/20 0.37
MAPK1 P28482 3/20 0.37
KDM4E B2RXH2 1/20 0.37
GAA P10253 3/20 0.36
LMNA P02545 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ACHE P22303 1/20 0.35
ALDH1A1 P00352 1/20 0.35
ALOX12 P18054 1/20 0.35
HTT P42858 1/20 0.35
FYN P06241 1/20 0.35
TP53 P04637 1/20 0.35
EPHX2 P34913 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10101769 0.89 S1PR1 (0.42) POLBSMN1; SMN2S1PR1MAPTMAPK1
SCHEMBL10102123 0.87 MAPT (0.50) SMN1; SMN2MAPTMAPK1LMNAMEN1
SCHEMBL10101757 0.87 S1PR1 (0.41) POLBHPGDSMN1; SMN2HSP90AA1S1PR1
SCHEMBL10101765 0.84 CA12 (0.44) POLBSMN1; SMN2S1PR1MAPTGAA
SCHEMBL10101760 0.84 L3MBTL1 (0.42) POLBHPGDS1PR1MAPTKDM4E
SCHEMBL10101774 0.84 BACE1 (0.40) POLBHPGDSMN1; SMN2S1PR1MAPT
SCHEMBL10101753 0.83 MAPK1 (0.41) POLBSMN1; SMN2S1PR1MAPTMAPK1
SCHEMBL10107079 0.81 HSP90AA1 (0.39) POLBHPGDSMN1; SMN2HSP90AA1S1PR1
SCHEMBL10101773 0.81 S1PR1 (0.43) POLBHSP90AA1S1PR1MAPTGAA
SCHEMBL10101767 0.79 S1PR1 (0.40) POLBS1PR1MAPTMAPK1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8536157-B2 Non-steroidal compounds THE UNIVERSITY OF MELBOURNE (AU) 2013-09-17 US disclosed
US-20120046255-A1 NON-STEROIDAL COMPOUNDS THE UNIVERSITY OF MELBOURNE of ROYAL PARADE PARKVILLE (AU) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046255-A1 NON-STEROIDAL COMPOUNDS PTGES2, PTGES, PTGES3 POLB 4460/4885HPGD 158/4885SMN1; SMN2 3060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.